Please login to the form below

Not currently logged in
Email:
Password:

Bayer UK and Ireland appoints new CEO

Lars Bruening succeeds Alex Moscho

Lars BrueningBayer has appointed a new UK and Ireland CEO in the form of Lars Bruening, who moves to its Reading, UK base from Berlin where he was head of the pharma group’s global market access business.

Prior to that Bruening held senior commercial roles in Europe, the Middle East and Asia, bringing knowledge in the pharmaceutical sector, international healthcare landscape and global commercial markets to the group.

He said: “Looking in from afar, the progress the UK and Ireland has made over the last four years alone, with the UK becoming the third largest Bayer market in Europe and the eighth largest in the world, as well as the progress made in individual markets also reflects the ongoing work with our partners and colleagues at the grassroots levels.

“It is this, which I am incredibly proud of and look forward to building upon this existing success.”

Bruening succeeds Alexander Moscho, who left Bayer after seven years to join UCB as its chief strategy officer.

16th October 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics